Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Small Dose of Sugammadex Improves Muscle Function After Standard Neuromuscular Recovery (TOF 0.9)

NCT01101139 is registered in ClinicalTrials.gov with Technical University of Munich as lead sponsor.

NCT NCT01101139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01101139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Small Dose of Sugammadex Improves Muscle Function After Standard Neuromuscular Recovery (TOF 0.9)
Lead sponsor
Technical University of Munich
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2010
Completion date
June 30, 2011
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuromuscular blockade